Inventprise Inc.

This early-stage study is testing a new vaccine called IVT Shigella-04 to prevent Shigella infections, which cause severe diarrhea. The trial involves 60 healthy adults aged 18 to 49 who will receive either the vaccine or a placebo. The main goal is to check the vaccine's safety …